The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy.

Tal SellaOlga KantorAnna WeissAnn H PartridgeOtto MetzgerTari A King

Published in: Breast cancer research and treatment (2022)

A minority of patients receive CT post-NET. This decision appears to be driven by younger age, RS and pathological nodal status. Increased consideration of these factors prior to neoadjuvant treatment choice may be warranted.

Keyphrases

lymph node
rectal cancer
locally advanced
end stage renal disease
ejection fraction
newly diagnosed
computed tomography
neoadjuvant chemotherapy
decision making
squamous cell carcinoma
stem cells
patient reported outcomes
combination therapy
cell therapy
replacement therapy